awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q47572918-CF52B40E-D86A-4894-8398-35870215C8EF
Q47572918-CF52B40E-D86A-4894-8398-35870215C8EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47572918-CF52B40E-D86A-4894-8398-35870215C8EF
A randomized phase II trial of ridaforolimus, dalotuzumab, and exemestane compared with ridaforolimus and exemestane in patients with advanced breast cancer.
P2860
Q47572918-CF52B40E-D86A-4894-8398-35870215C8EF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q47572918-CF52B40E-D86A-4894-8398-35870215C8EF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7575f51d6aa7a0b87d6e9d7286a62e000a8cf2d1
P2860
NCIC CTG IND.190 phase I trial of dalotuzumab (MK-0646) in combination with cisplatin and etoposide in extensive-stage small-cell lung cancer.